scholarly article | Q13442814 |
P2093 | author name string | Schwartz ME | |
Emre S | |||
Miller CM | |||
Sheiner PA | |||
Altaca G | |||
Soejima Y | |||
Fishbein TM | |||
Facciuto M | |||
P2860 | cites work | Accuracy and significance of computed tomographic scan assessment of hepatic volume in patients undergoing liver transplantation | Q33857232 |
Functional analysis of grafts from living donors. Implications for the treatment of older recipients. | Q46664890 | ||
Auxiliary partial orthotopic living donor liver transplantation as an aid for small-for-size grafts in larger recipients | Q47263694 | ||
Impact of graft size mismatching on graft prognosis in liver transplantation from living donors | Q47271534 | ||
Standard liver volume in the Caucasian population. | Q52205356 | ||
MINIMUM GRAFT VOLUME FOR SUCCESSFUL ADULT-TO-ADULT LIVING DONOR LIVER TRANSPLANTATION FOR FULMINANT HEPATIC FAILURE | Q58236334 | ||
P433 | issue | 1 | |
P921 | main subject | liver transplantation | Q1368191 |
P304 | page(s) | 41-47 | |
P577 | publication date | 2001-01-01 | |
P1433 | published in | Liver Transplantation | Q15730498 |
P1476 | title | Safety and risk of using pediatric donor livers in adult liver transplantation | |
P478 | volume | 7 |
Q47449789 | A simple new formula to assess liver weight |
Q99579006 | Adult liver transplantation using pediatric donor livers after cardiac or brain death: A report of three cases |
Q37206214 | Child-to-Adult Liver Transplantation With Donation After Cardiac Death Donors: Three Case Reports |
Q36278648 | Comparison of techniques for volumetric analysis of the future liver remnant: implications for major hepatic resections. |
Q62618489 | Daclizumab induction and maintenance steroid-free immunosuppression with mycophenolate mofetil and tacrolimus to prevent acute rejection of hepatic allografts |
Q57597724 | Feasibility and limits of split liver transplantation from pediatric donors: an italian multicenter experience |
Q91578159 | Hepatic Artery Thrombosis in Liver Transplantation in Adult Recipients Using Pediatric Deceased Donors |
Q44067844 | Long-term safety, tolerability and efficacy of daclizumab (Zenapax) in a two-dose regimen in liver transplant recipients |
Q52565360 | Measurement of Total Liver Volume Using the Energy Expenditure: A New Formula. |
Q54965841 | Outcomes of Liver Transplantation Using Pediatric Deceased Donor Livers: A Single-Center Analysis of 102 Donors. |
Q39795437 | Outcomes of liver transplantation with liver grafts from pediatric donors used in adult recipients |
Q50522210 | Pediatric Donor to Adult Recipients in Donation After Cardiac Death Liver Transplantation: A Single-Center Experience. |
Q52617022 | Receipt of a pediatric liver offer as the first offer reduces waitlist mortality for adult women. |
Q40113551 | Small-for-Size Syndrome: Bridging the Gap Between Liver Transplantation and Graft Recovery |
Q41395487 | Using pediatric liver grafts (≤ 6 yr) for adult recipients: A considerable option? |
Search more.